TRAVERE THERAPEUTICS INC COM is a security (CUSIP 89422G107) tracked across SEC portfolio filings. 297 institutional managers reported $3.4B on Form 13F as of 2026-06-30; 41 registered fund positions totaling $215.7M via N-PORT as of 2026-05-31.
Showing 15 of 297 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | LONDON, X0 | $339.2M | 11,419,586 |
| FMR LLC | BOSTON, MA | $325.9M | 10,967,967 |
| VANGUARD GROUP INC | Valley Forge, PA | $241.1M | 6,309,229 |
| BlackRock, Inc. | New York, NY | $231.5M | 7,792,033 |
| STATE STREET CORP | BOSTON, MA | $147.4M | 4,959,988 |
| ARMISTICE CAPITAL, LLC | NEW YORK, NY | $145.5M | 4,897,417 |
| PERCEPTIVE ADVISORS LLC | NEW YORK, NY | $123.1M | 4,142,551 |
| Stephens Investment Management Group LLC | LITTLE ROCK, AR | $106.5M | 1,875,304 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | PHILADELPHIA, PA | $97.2M | 3,270,513 |
| EMERALD ADVISERS, LLC | LEOLA, PA | $90.9M | 1,600,886 |
| Kynam Capital Management, LP | PRINCETON, NJ | $72.0M | 1,569,018 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $70.4M | 2,369,559 |
| EMERALD MUTUAL FUND ADVISERS TRUST | LEOLA, PA | $58.6M | 1,032,024 |
| RENAISSANCE TECHNOLOGIES LLC | NEW YORK, NY | $58.4M | 1,966,779 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $51.1M | 1,719,721 |
Showing 15 of 41 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $51.8M | 23.78% |
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $29.7M | 3.64% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $20.0M | 11.40% |
| Janus Henderson Venture Fund | JANUS INVESTMENT FUND | $17.9M | 58.40% |
| Emerald Growth Fund | FINANCIAL INVESTORS TRUST | $17.1M | 121.60% |
| Fidelity Advisor Health Care Fund | Fidelity Advisor Series VII | $12.2M | 42.31% |
| VANGUARD STRATEGIC EQUITY FUND | VANGUARD HORIZON FUNDS | $11.1M | 11.01% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $10.5M | 92.30% |
| T. Rowe Price Small-Cap Stock Fund, Inc. | T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | $6.8M | 8.47% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $6.1M | 108.02% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $4.1M | 8.45% |
| T. Rowe Price Institutional Small-Cap Stock Fund | T. Rowe Price Equity Funds, Inc. | $3.7M | 8.62% |
| VOYA SMALL COMPANY PORTFOLIO | Voya VARIABLE PORTFOLIOS INC | $3.1M | 171.50% |
| Goldman Sachs ActiveBeta(R) U.S. Small Cap Equity ETF | Goldman Sachs ETF Trust | $2.6M | 26.04% |
| TIFF MULTI-ASSET FUND | TIFF Investment Program | $2.6M | 18.43% |